Phase 2b study in Clenbuterol/nadolol in Major-depressive-disorder who also suffer from cognitive decline
Latest Information Update: 16 Oct 2024
At a glance
- Drugs Clenbuterol/nadolol (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 16 Oct 2024 New trial record